Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINISK TANDTEKNIKER SASHA PALLISBECK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.9% 2.9% 1.8% 2.1% 2.3% 30.6% 16.1% 15.9%   Credit score (0-100)   71 60 71 66 64 1 11 12   Credit rating   A BBB A A BBB C BB BB   Credit limit (kDKK)   0.3 0.0 0.7 0.2 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,239 2,489 1,749 2,233 2,329 1,257 0.0 0.0   EBITDA   721 1,135 393 478 530 -865 0.0 0.0   EBIT   612 1,058 359 453 524 -1,039 0.0 0.0   Pre-tax profit (PTP)   608.0 1,051.0 340.0 437.0 512.0 -1,047.4 0.0 0.0   Net earnings   473.0 818.0 257.0 335.0 386.0 -1,057.8 0.0 0.0   Pre-tax profit without non-rec. items   608 1,051 340 437 512 -1,047 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   115 71.0 32.0 5.0 0.0 333 0.0 0.0   Shareholders equity total   772 590 747 832 668 -390 -470 -470   Interest-bearing liabilities   0.0 440 380 419 328 347 470 470   Balance sheet total (assets)   1,244 1,240 1,509 1,640 1,346 380 0.0 0.0   Net Debt   -356 -663 -974 -1,108 -771 346 470 470     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,239 2,489 1,749 2,233 2,329 1,257 0.0 0.0   Gross profit growth   -11.9% 11.2% -29.7% 27.7% 4.3% -46.0% -100.0% 0.0%   Employees   4 3 3 4 7 7 0 0   Employee growth %   0.0% -25.0% 0.0% 33.3% 75.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,244 1,240 1,509 1,640 1,346 380 0 0   Balance sheet change%   -14.7% -0.3% 21.7% 8.7% -17.9% -71.8% -100.0% 0.0%   Added value   721.0 1,135.0 393.0 478.0 549.0 -864.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -197 -121 -73 -52 -11 158 -333 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.3% 42.5% 20.5% 20.3% 22.5% -82.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   45.5% 85.3% 26.1% 28.8% 35.1% -97.9% 0.0% 0.0%   ROI %   65.3% 115.9% 31.8% 37.0% 46.6% -154.3% 0.0% 0.0%   ROE %   50.5% 120.1% 38.4% 42.4% 51.5% -201.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   62.1% 47.6% 49.5% 50.7% 50.9% -53.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -49.4% -58.4% -247.8% -231.8% -145.5% -40.0% 0.0% 0.0%   Gearing %   0.0% 74.6% 50.9% 50.4% 49.1% -89.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.1% 4.6% 4.0% 3.2% 3.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 1.9 2.1 2.0 2.1 0.1 0.0 0.0   Current Ratio   2.4 1.9 2.1 2.0 2.0 0.0 0.0 0.0   Cash and cash equivalent   356.0 1,103.0 1,354.0 1,527.0 1,099.0 1.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   649.0 534.0 778.0 817.0 658.0 -732.4 -235.0 -235.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   180 378 131 120 78 -124 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   180 378 131 120 76 -124 0 0   EBIT / employee   153 353 120 113 75 -148 0 0   Net earnings / employee   118 273 86 84 55 -151 0 0